-
Product Insights
Guodian Changchun Power Plant
Guodian Changchun Power Plant is a thermal project located in Jilin, China. The project is owned by China Energy Investment Corp Ltd. The project came online in 2011. Empower your strategies with our Guodian Changchun Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
Huaneng Changchun Biomass Power Plant
Huaneng Changchun Biomass Power Plant is a biopower project located in Jilin, China. The project came online in 2009. Empower your strategies with our Huaneng Changchun Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...
-
Product Insights
Changchun No. 4 Thermal Power Project
Changchun No. 4 Thermal Power Project is a thermal project located in Jilin, China. The project is owned by Huaneng Power International Inc. The project came online in 2009. Empower your strategies with our Changchun No. 4 Thermal Power Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
Changchun No.3 Thermal Power Plant
Changchun No.3 Thermal Power Plant is a thermal project located in Jilin, China. The project is owned by Datang Jilin Power Generation Co Ltd. The project is currently active. Empower your strategies with our Changchun No.3 Thermal Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Company Insights
Innovation and Patenting activity of Changchun High-tech Industrial (Group) Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Changchun High-tech Industrial (Group) Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRGN-3007 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRGN-3007 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRGN-3007 in Solid Tumor Drug Details: PRGN-3007 is under development for...
-
Product Insights
Rickets – Drugs In Development, 2023
Global Markets Direct’s, ‘Rickets - Drugs In Development, 2023’, provides an overview of the Rickets pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rickets, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Precocious Puberty – Drugs In Development, 2023
Global Markets Direct’s, ‘Precocious Puberty - Drugs In Development, 2023’, provides an overview of the Precocious Puberty pipeline landscape. The report provides comprehensive information on the therapeutics under development for Precocious Puberty , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides...
-
Product Insights
Pancreatic Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Pancreatic Tumor - Drugs In Development, 2023’, provides an overview of the Pancreatic Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatic Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Growth Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Growth Disorders - Drugs In Development, 2023’, provides an overview of the Growth Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Growth Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...